600332.SHG Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
23.30 CNY
Close of Nov 5, 2026
19.14 27.50
Market cap
CNY 32.8B
P/E
15.2x
P/B
0.84x
ROE
8.5%
Dividend yield
3.97%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600332.SHG undervalued?

Graham number
Price23.30
Graham value30.92
Discount24.6%

600332.SHG trades 24.6% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd fundamental analysis

No fundamental analysis for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd yet.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the pharmaceutical and healthcare industry in the People's Republic of China and internationally. The company operates through Modern Chinese Medicine Business, Chemical Pharmaceutical Technology Business, Natural Beverage Business, Pharmaceutical Commercial Business, and Other segments. It is involved in the research, development, manufacturing, and sale of chemical drugs, chemical raw materials, and ch…

Full company profile